Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

By Patel Hardik J   Modi Shanu   Chiosis Gabriela   Taldone Tony  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 559-587

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010

By Messaoudi Samir   Peyrat Jean-François   Brion Jean-Daniel   Alami Mouad  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 10, 2011-10 ,pp. : 1501-1542

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up?

By Isaacs Jennifer S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 569-589

Informa Healthcare

Access to resources Recommend Favorite

Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives

By Kim TaeHun   Keum Gyochang   Pae Ae Nim  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 919-943

Informa Healthcare

Access to resources Recommend Favorite